Methods for processing biological tissue

• US 7,622,276 B2
• Filed: 06/06/2006
• Issued: 11/24/2009
• Est. Priority Date: 01/11/2005
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Arbor Surgical Technologies, Inc. (Medtronic Plc)
• Inventors: Cunanan, Crystal M., Cambron, Ronald E., Ochoa, Alexandro
• Primary Examiner(s): Lankford; Leon B.
• Assistant Examiner(s): FERNANDEZ, SUSAN EMILY
• Application Number:
  US11/422,576
• Publication Number:
  US 20060207031A1
• Time in Patent Office: 1,267 Days
• Field of Search: 435/40.5, 435/40.51, 435/40.52, 435/40.41
• US Class Current: 435/40.52
• CPC Class Codes: A01N 1/02 Preservation of living parts
• CPC Class Codes: A01N 1/0226 Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients

Abstract

A method for processing biological tissue used in biological prostheses includes providing a tissue procurement solution formed from a phosphate buffered saline (PBS) solution and a chelating agent. The tissue is transferred from the tissue procurement solution and undergoes chemical fixation. The fixed tissue is then immersed in a series of fresh bioburden reduction process (BRP) solutions to extract phospholipids. The tissue procurement solution reduces the bioburden on the stored tissue and preserves tissue architecture by minimizing tissue swelling. The tissue procurement solution further reduces calcium from the incoming water and/or tissue, and inhibits enzymes that digest the collagen matrix. The serial immersion of the tissue in the fresh bioburden solutions ensures optimal extraction of phospholipids thereby mitigating subsequent calcification of the tissue.

Claims

1. A method for processing fixed biological tissue to remove phospholipids comprising the steps of:

(a) immersing the fixed biological tissue in a first fresh bioburden reduction process (BRP) solution, wherein the phospholipids are soluble in the first BRP solution, and wherein the first BRP solution consists essentially of purified water, glutaraldehyde, polysorbate-80, and a buffer to maintain a pH within the range of about 7.3 to 7.5 during processing;

(b) heating the first fresh BRP solution to a temperature of about 37°

C. to remove phospholipids from the tissue;

(c) removing the fixed biological tissue from the fresh BRP solution;

(d) immediately immersing the fixed biological tissue in a next fresh BRP solution having a composition substantially the same as the first fresh BRP solution; and

(e) heating the next fresh BRP solution to a temperature of about 37°

C. to remove phospholipids from the tissue to mitigate or reduce calcification of the tissue.

2. The method of claim 1, further comprising the steps of repeating steps (c), (d), and (e) one or more times.

3. The method of claim 1, wherein, in steps (b) and (e), the BRP solution is heated for a period of time between four and sixteen hours.

4. The method of claim 1, wherein the total time the fixed tissue is exposed to BRP solution is no more than about twenty-four hours.

9. The method of claim 1, wherein the fixed biological tissue comprises a leaflet attached to a frame.

10. The method of claim 9, wherein the fixed biological tissue further comprises fabric covering at least a portion of the frame.

11. The method of claim 9, further comprising:

rinsing the fixed biological tissue; and

assembling the frame to a valve frame.

12. The method of claim 1, further comprising cutting the fixed biological tissue into leaflets before steps (a)-(e).

13. The method of claim 1, wherein the fixed biological tissue is fixed before steps (a)-(e) by a process comprising:

cutting biological tissue into strips;

immersing the strips in fixation solution by one end of the strips with a weight on a lower end of the strips to subject the biological tissue to uniaxial fixation.

19. The method of claim 1, wherein the buffer comprises sodium chloride, potassium phosphate monobasic, sodium phosphate dibasic heptahydrate, and one or both of hydrochloric acid and sodium hydroxide as needed to maintain the pH within the range of about 7.3 to 7.5 during processing.

20. The method of claim 1, wherein the buffer consists essentially of sodium chloride, potassium phosphate monobasic, sodium phosphate dibasic heptahydrate, and one or both of hydrochloric acid and sodium hydroxide as needed to maintain the pH within the range of about 7.3 to 7.5 during processing.

5. A method for processing fixed biological tissue to remove phospholipids comprising the steps of:

immersing the fixed biological tissue using a co-current, cross-current, or counter-current separation system comprising a fresh bioburden reduction process (BRP) solution, the BRP solution consisting essentially of purified water, glutaraldehyde, polysorbate-80, and a buffer to maintain a pH within the range of about 7.3 to 7.5 during processing; and

heating the fresh BRP solution to a temperature of about 37°

C. to substantially continuously remove phospholipids from the tissue to mitigate or reduce calcification of the tissue.

6. The method of claim 5, wherein the immersion takes place in a co-current separation system.

7. The method of claim 5, wherein the immersion takes place in a cross-current separation system.

8. The method of claim 5, wherein the immersion takes place in a counter-current separation system.

21. The method of claim 5, wherein the buffer comprises sodium chloride, potassium phosphate monobasic, sodium phosphate dibasic heptahydrate, and one or both of hydrochloric acid and sodium hydroxide as needed to maintain the pH within the range of about 7.3 to 7.5 during processing.

22. The method of claim 5, wherein the buffer consists essentially of sodium chloride, potassium phosphate monobasic, sodium phosphate dibasic heptahydrate, and one or both of hydrochloric acid and sodium hydroxide as needed to maintain the pH within the range of about 7.3 to 7.5 during processing.

14. A method for processing fixed biological tissue using a bioburden reduction process (BRP) solution comprising glutaraldehyde and polysorbate-80 to remove phospholipids, the method comprising:

(a) attaching the fixed biological tissue to a laminate or frame;

(b) covering the laminate or frame at least partially with fabric to create a leaflet sub-assembly;

(c) immersing the leaflet sub-assembly in a first container of the BRP solution, the BRP solution consisting essentially of purified water, glutaraldehyde, polysorbate-80, and a buffer to maintain a pH within the range of about 7.3 to 7.5 during processing;

(d) heating the first container to a temperature of about 37°

C. for a period of time between about four and sixteen (4-16) hours to remove phospholipids from the tissue using the BRP solution;

(e) removing the leaflet sub-assembly from the first container;

(f) immediately immersing the leaflet sub-assembly in a second container of the BRP solution; and

(g) heating the second container to a temperature of about 37°

C. to remove phospholipids from the tissue using the BRP solution,

wherein the total time the tissue is exposed to the BRP solution is no more than about twenty-four hours to mitigate or reduce calcification of the tissue.

15. The method of claim 14, further comprising:

rinsing the leaflet sub-assembly; and

assembling the leaflet sub-assembly to a valve frame.

16. The method of claim 14, further comprising cutting the fixed biological tissue into a plurality of leaflets, wherein each of the leaflets are processed using steps (a)-(g).

17. The method of claim 14, further comprising:

removing the leaflet sub-assembly from the second container;

immediately immersing the leaflet sub-assembly in a third container of the BRP solution.

18. The method of claim 14, wherein the first container is reused as the second container.

23. The method of claim 14, wherein the buffer comprises sodium chloride, potassium phosphate monobasic, sodium phosphate dibasic heptahydrate, and one or both of hydrochloric acid and sodium hydroxide as needed to maintain the pH within the range of about 7.3 to 7.5 during processing.

24. The method of claim 14, wherein the buffer consists essentially of sodium chloride, potassium phosphate monobasic, sodium phosphate dibasic heptahydrate, and one or both of hydrochloric acid and sodium hydroxide as needed to maintain the pH within the range of about 7.3 to 7.5 during processing.